Nattakanwadee Khumpirapang

Dr. Nattakanwadee Khumpirapang

Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Phytomedicine
Verified
Journal Article
Closed access
RSRoswitha Schuster
Roswitha Schuster
LZLaura Zeindl
Laura Zeindl
WHWolfgang Holzer
Wolfgang Holzer
Nattakanwadee KhumpirapangNattakanwadee Khumpirapang
Nattakanwadee Khumpirapang
SOSiriporn Okonogi
Siriporn Okonogi
MMMonika Mueller
Monika Mueller

1 November 2018 in Aquaculture
Verified
Journal Article
Closed access
Nattakanwadee KhumpirapangNattakanwadee Khumpirapang
Nattakanwadee Khumpirapang
SCSiripat Chaichit
Siripat Chaichit
SJSupat Jiranusornkul
Supat Jiranusornkul
SPSurachai Pikulkaew
Surachai Pikulkaew
AMAnette Mullertz
Anette Mullertz
SOSiriporn Okonogi
Siriporn Okonogi

15 February 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Nattakanwadee KhumpirapangNattakanwadee Khumpirapang
Nattakanwadee Khumpirapang
SKSrikanjana Klayraung
Srikanjana Klayraung
Singkome TimaSingkome Tima
Singkome Tima
SOSiriporn Okonogi
Siriporn Okonogi
The aim of the present study was to develop a microemulsion (ME) containing Alpinia galanga oil (AGO), 1,8-cineole (C), or methyl eugenol (M) as an active pharmaceutical ingredient (API) for enhancing their antimicrobial activities. Agar diffusion, broth microdilution, and killing kinetics were used for antimicrobial evaluations. The ME composed of 30% API, 33.4% Tween 80, 16.6% ethanol, and 20% water appeared as translucent systems with droplet size and polydispersity index of 101.1 ± 1.3 nm and 0.3 ± 0.1, 80.9 ± 1.1 nm and 0.4 ± 0.1, and 96.6 ± 2.0 nm and 0.2 ± 0.1 for ME-AGO, ME-C, and ME-M, respectively. These ME formulations showed minimum bacterial concentrations of 3.91–31.25 µg/mL and 50% fungal inhibition concentrations of 1.83 ± 0.27–0.46 ± 0.13 µg/mL, 2–4 times stronger, and faster kinetic killing rate than their respective API alone. Keeping the ME formulations at 4 °C, 25 °C, and 40 °C for 12 weeks did not affect their activities against fungi and Gram-negative bacteria, but the high temperature of 40 °C decreased their activities against Gram-positive bacteria. It is concluded that ME is a promising delivery system for AGO and its major compounds to enhance their water miscibility and antimicrobial activities.

23 January 2018 in Aquaculture Research
Verified
Journal Article
Closed access
PDF file
Nattakanwadee KhumpirapangNattakanwadee Khumpirapang
Nattakanwadee Khumpirapang
SPSurachai Pikulkaew
Surachai Pikulkaew
Songyot AnuchapreedaSongyot Anuchapreeda
Songyot Anuchapreeda
SOSiriporn Okonogi
Siriporn Okonogi

30 November 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Nattakanwadee KhumpirapangNattakanwadee Khumpirapang
Nattakanwadee Khumpirapang
SPSurachai Pikulkaew
Surachai Pikulkaew
AMAnette Mullertz
Anette Mullertz
TRThomas Rades
Thomas Rades
SOSiriporn Okonogi
Siriporn Okonogi
Alpinia galanga oil (AGO) possesses various activities but low aqueous solubility limits its application particularly in aquatic animals. AGO has powerful activity on fish anesthesia. Ethanol used for enhancing water miscible of AGO always shows severe side effects on fish. The present study explores the development of self-microemulsifying drug delivery systems (SMEDDS) and nanoemulsions (NE) to deliver AGO for fish anesthesia with less or no alcohol. Pseudoternary phase diagrams were constructed to identify the best SMEDDS-AGO formulation, whereas NE-AGO were developed by means of high-energy emulsification. The mean droplet size of the best SMEDDS-AGO was 82 ± 0.5 nm whereas that of NE-AGO was 48 ± 1.6 nm. The anesthetic effect of the developed SMEDDS-AGO and NE-AGO in koi (Cyprinus carpio) was evaluated and compared with AGO ethanolic solution (EtOH-AGO). It was found that the time of induction the fish to reach the surgical stage of anesthesia was dose dependent. NE-AGO showed significantly higher activity than SMEDDS-AGO and EtOH-AGO, respectively. EtOH-AGO caused unwanted hyperactivity in the fish. This side effect did not occur in the fish anesthetized with SMEDDS-AGO and NE-AGO. In conclusion, SMEDDS and NE are promising delivery systems for AGO.

1 January 2017 in Drug Discoveries & Therapeutics
Verified
Journal Article
Open access
PDF file
SPSurachai Pikulkaew
Surachai Pikulkaew
Nattakanwadee KhumpirapangNattakanwadee Khumpirapang
Nattakanwadee Khumpirapang
Wasana ChaisriWasana Chaisri
Wasana Chaisri
SOSiriporn Okonogi
Siriporn Okonogi
Oreochromis niloticus (Nile tilapia) is one widely cultured fish in Thailand. Handling processes and transportation causes high stress in Nile tilapia. This study explores anesthetic effect and stress reduction of Alpinia galanga oil (AGO) on Nile tilapia. The anesthetic activity was evaluated by the time for fish induction to anesthesia and full recovery. It was found that the suitable dose of AGO that caused desirable anesthesia of Nile tilapia was 700 mg/L. This dose gave induction and recovery times of approximately 257 and 438 sec, respectively. Blood glucose and plasma cortisol of the fish anesthetized with AGO showed nearly normal levels indicating that the fish stress during handling was not increased. Study on loading densities of fish mimicked general fish transportation and showed that loading density of fish was a crucial factor on fish stress. The highest water quality was found in the lowest loading density of fish. Water containing AGO at a concentration of 150 mg/L showed significantly higher potential for reducing fish activity and water improvement than without AGO. Therefore, AGO is a promising natural edible plant oil for anesthesia in Nile tilapia.